← Back to Discover
venBio Partners LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $519,380,257
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PHARVARIS N V · COM · N69605108 · shares: $160,569,809
- PARABILIS MEDICINES INC · COM · 698955101 · shares: $144,149,497
- ALUMIS INC · COM · 022307102 · shares: $127,429,401
- ACHIEVE LIFE SCIENCE INC · COM · 004468500 · shares: $38,623,122
- ALX ONCOLOGY HLDGS INC · COM · 00166B105 · shares: $26,671,201
- HARMONY BIOSCIENCES HLDGS IN · COM · 413197104 · shares: $17,192,584
- LYELL IMMUNOPHARMA INC · COM NEW · 55083R203 · shares: $4,744,643
Reported holdings
7 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PHARVARIS N V | COM | N69605108 | — | 4,643,430 shares | $160,569,809 |
| PARABILIS MEDICINES INC | COM | 698955101 | — | 5,266,697 shares | $144,149,497 |
| ALUMIS INC | COM | 022307102 | — | 4,528,408 shares | $127,429,401 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 5,914,720 shares | $38,623,122 |
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | — | 12,884,638 shares | $26,671,201 |
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | — | 472,194 shares | $17,192,584 |
| LYELL IMMUNOPHARMA INC | COM NEW | 55083R203 | — | 337,697 shares | $4,744,643 |